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Cerebral pressure autoregulation and carbon dioxide reactivity
during propofol-induced EEG suppression
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Summary
We studied cerebral pressure autoregulation and
carbon dioxide reactivity during propofol-induced
electrical silence of the electroencephalogram
(EEG) in 10 patients. Anaesthesia was induced
with propofol 2.5 mg kg"1, fentanyl 3 ug kg"1 and
vecuronium 0.1 mg kg"1, and a propofol infusion of
250-300 ug kg"1 min"1 was used to induce EEG
silence. Cerebral pressure autoregulation was tested
by increasing mean arterial pressure (MAP) by 24
(SEM 5) mm Hg from baseline with an infusion of
phenylephrine and simultaneously recording middle
cerebral artery blood flow velocity (i/mca) using
transcranial Doppler. Carbon dioxide reactivity was
tested by varying PaCo2 between 4.0 and 7.0 kPa
and recording ymca simultaneously. Although ab-
solute carbon dioxide reactivity was reduced,
relative carbon dioxide reactivity was within normal
limits for all patients studied (mean 8.5
(SEM 0.8) cm s"1 kPa"1 and 22 (2)% kPa~1, respect-
ively). No significant change in i/mca (34 (2) and
35 (2) cms"1) was observed with the increase in
MAP (77 (4) to 101 (4) mm Hg) during auto-
regulation testing. We conclude that cerebral car-
bon dioxide reactivity and pressure autoregulation
remain intact during propofol-induced isoelectric
EEG. {Br. J. Anaesth. 1995; 74: 159-163)
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Cerebral pressure autoregulation and vasoreactivity
to carbon dioxide, two homeostatic mechanisms
important for the control of cerebral blood flow
(CBF), are impaired by pathology and some drugs
used commonly during anaesthesia [1-5]. With the
exception of ketamine, most commonly used i.v.
anaesthetic agents depress also cerebral metabolism
in a dose-dependent manner. As typified by the
barbiturates, this depression is associated with a
reduction in cerebral metabolic requirements for
oxygen (CMRo2) and CBF, which stabilize when
electroencephalographic (EEG) activity becomes
isoelectric [6, 7]. Barbiturate-induced cortical sup-
pression has been advocated as a method of cerebral
protection during temporary occlusion of any vessel
that provides nutrients to the central nervous system
[8]. Although such use is well documented, it is
associated with prolonged awakening which is un-
desirable in neurosurgical patients. Propofol has
similar cerebrovascular effects as thiopentone [9] and
because of its pharmacokinetic profile, it may be
suitable for this purpose. If propofol is to be used for
cerebral protection, in high enough doses to produce
EEG suppression, it is important to know the effects
of complete EEG suppression on cerebral pressure
autoregulation and carbon dioxide reactivity. The
purpose of this study was to determine if cerebral
carbon dioxide reactivity and pressure auto-
regulation remain intact during propofol-induced
isoelectric EEG.
Patients and methods
After obtaining local Ethics Committee approval and
informed written consent, we examined carbon
dioxide reactivity and pressure autoregulation dur-
ing propofol-induced isoelectric EEG in 10 patients
(ASA I or II, mean age 37 (range 23-44) yr, weight
76 (SD 10) kg) undergoing anaesthesia for non-
neurosurgical procedures. Patients who had car-
diovascular, respiratory or neurological disease, and
those receiving psychotropic drugs were excluded.
After commencing routine monitoring (ECG, non-
invasive arterial pressure and pulse oximetry),
anaesthesia was induced with propofol 2.5 mg kg"1
and fentanyl 3ugkg"'. Neuromuscular block was
produced with vecuronium 0.1 mg kg"1 and the lungs
ventilated with an air-oxygen mixture to maintain
normocapnia (PaC02 5.3 (SD 1) kPa). Anaesthesia was
maintained with a propofol infusion of either 250 or
300 u.g kg"1 min"1 to produce isoelectricity of the
EEG and the rate of infusion remained unchanged
for the duration of the study. Repeated doses of
vecuronium were used to maintain neuromuscular
block. A radial arterial catheter was then inserted for
continuous monitoring of mean arterial pressure
(MAP) and repeated sampling for measurement of
blood-gas tensions.
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Cerebral blood flow velocity was measured by
insonating the right middle cerebral artery (MCA)
using a 2-MHz transcranial Doppler probe (Multidop
by DWL, Sipplingen, Germany) through the tem-
poral window. This method has been reported
previously [10]. Briefly, the probe was secured in
position so that the angle of insonation remained
constant throughout the study. Doppler signals from
the right MCA were identified and measured at a
depth of 45—50 mm. The shift in frequency spectra
of the Doppler signals converted into time—mean
peak flow velocity (zimca) were displayed on a video
monitor. To reduce ventilatory effects, measure-
ments were obtained only during end-expiration and
averaged over 3-4 cycles. Brain electrical activity
was monitored using a two-channel fronto-occipital
montage (Spacelab, Redmond, WA, USA), using a
module which displayed unprocessed EEG signals.
In all patients, an infusion of 0.01 % phenylephrine
was used to maintain mean MAP within the normal
range of 70-90 mm Hg.
After 5-15 min of isoelectric EEG, relatively stable
arterial pressure and normocapnia, the infusion rate
of phenylephrine was increased so as to elevate MAP
by approximately 20 mm Hg from baseline and vmca
was recorded simultaneously. The infusion rate of
phenylephrine was then decreased and MAP allowed
to return to baseline. Carbon dioxide reactivity was
then tested by varying Pacc>2 between 4.0 and 7.0 kPa
and recording vmca simultaneously. Arterial Pacc,2
was varied by altering minute ventilation, primarily
by changing the rate so that inspiratory pressure
remained relatively constant. A minimum of 5 min
for stabilization (unchanged end-tidal carbon di-
oxide) was allowed at each PaCo2 before measure-
ments were made. Three pairs of PaC02-vmca data
were obtained in each patient for determination of
carbon dioxide reactivity.
The index of autoregulation (IOR) was denned as
the ratio of percentage change in estimated cerebral
vascular resistance to percentage change in MAP.
Estimated cerebral vascular resistance (CVRe) was
calculated using the equation CVRe = MAP/vmca,
where MAP = mean arterial pressure at the time of
wmca measurement. An unchanged vmca would
theoretically occur if the percentage change in CVRe
was equal to the percentage change in MAP. Thus an
IOR of 1 implies perfect autoregulation and an IOR
of 0 complete absence of autoregulation (IOR =
%ACVRe/%AMAP). Based on a dynamic auto-
regulation study [11], we considered a 15% change
in IOR to be clinically insignificant. For a power of
0.80, an a error of 0.05 and a P error of 0.20, the
required number of patients to reject the null
hypothesis was 10. The computed IOR and data
recorded before and after the phenylephrine-induced
increase in MAP were analysed using Student's
paired t test. P < 0.05 was considered statistically
significant.
To determine carbon dioxide reactivity, regression
lines were constructed for the paired PaCO2-vmca
data for each patient. Relative vmca was expressed
also as a percentage of timca at a Pacc,2 of 5.3 kPa for
all patients. Carbon dioxide reactivity was expressed
in both absolute (change in vmca per kPa change in
PaC02) and relative values (percentage change in
vmca per kPa change in Pacc,2). For percentage
changes, vmca was normalized to vmca at a Pacc,2 of
5.3 kPa.
Results
The major findings of the study are shown in table 1
and figures 1-3. There was no significant change in
patients' body temperature, haemoglobin concen-
tration or partial pressure of oxygen (PaO2) in
arterial blood during the course of the study (table
1). There was no change in PaCO2 during the
autoregulation part of the study and no change in
MAP during the carbon dioxide reactivity part of the
study. The autoregulation data are shown in table 1.
An increase in MAP of mean 24 (SEM 5) mm Hg had
no effect on vmca. IOR was 0.93 (0.02) and was not
significantly different from 1, indicating near perfect
autoregulation. A representative trace is shown in
figure 1.
Linear regression analysis demonstrated a close
relationship between vmca and Pacc,2, with cor-
relation coefficients greater than 0.90 in all instances
(P < 0.001). Although absolute cerebral vaso-
reactivity to carbon dioxide derived by linear
regression analysis was lower than reported awake
values, relative cerebral vasoreactivity to carbon
dioxide was within normal limits for all patients
studied (8.5 (SEM 0.8) cm s"1 kPa"1 and 22
(2) % kPa"1, respectively). Absolute vmca vs PaCo2 for
all paired data and the respective linear regression
lines (slopes) are shown in figure 2. Figure 3 shows
Table I Temperature and haemodynamic data during pressure
autoregulation (mean (SEM)). ** P < 0.01 compared with
baseline (Student's paired t test)
Haemoglobin (g dl~')
Temperature (°C)
MAP (mm Hg)
Heart rate (beat min"1)
PaC0; (kPa)
vma (cm s ')
Baseline
10.7(1)
36.0 (0.3)
77(4)
67(4)
5.3(0.8)
34(2)
Autoregulation
10.6(1)
35.9 (0.2)
101 (4)**
64(6)
5.2 (0.7)
35(2)
100
50
MAP (mm
vmca (cm s"1)
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Figure 1 Representative trace of autoregulation during
propofol-induced EEG silence showing mean arterial pressure
(MAP), mean cerebral blood flow velocity (nmca) and
unprocessed EEG activity. Because of flow-metabolism
coupling, the onset of EEG silence is associated with a sudden
decrease in Dmca.
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Figure 2 Absolute cerebral blood flow velocity rmca; is the
corresponding Paco. value for all patients studied. The dashed
lines indicate individual patient absolute carbon dioxide
reactivity, the solid line represents mean (SEM) carbon dioxide
reactivitv.
200
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jo
50
3 4 5 6 7
PaC0?(kPa»
Figure 3 Composite plot of relative middle cerebral artery
velocity (umca) vs the corresponding PaCo2 value for all patients
studied. Relative wnca was calculated by expressing flow
velocity values as a percentage of wnca at a Pacc,2 of 5.3 kPa.
The respective linear regression is shown.
relative cerebral vasoreactivity (relative wmca vs
PaCo2). Normalization is necessary to allow pooling
of data with different baseline values.
Discussion
We have shown that during propofol-induced iso-
electric EEG, both cerebral pressure autoregulation
and carbon dioxide reactivity are intact. This
suggests that both of these mechanisms are not
dependent on cortical activity. The findings have
important clinical implications as there is some
experimental evidence which suggests that propofol
has cerebral protective properties when used in high
enough doses to induce EEG suppression [12].
There was no significant difference in patients'
body temperature or haemoglobin concentration
during the course of the study. Haemoglobin can
affect flow velocity as haemodilution decreases
viscosity and increases CBF and flow velocity [13].
Steady-state conditions were maintained during both
parts of the study; MAP was maintained constant
during the carbon dioxide reactivity part of the
study, whereas P a ^ was unchanged between normo-
tension and phenylephrine-induced hypertension
phases. The only other drug used was fentanyl,
which has no direct cerebrovascular effects [14].
Using transcranial Doppler ultrasonography
(TCD) it is possible to measure CBF velocity in a
non-invasive continuous manner. However, CBF
velocity is not a direct measure of CBF. Although
techniques to measure CBF, such as radioactive
xenon, are available, these are cumbersome and
slow, require steady state and allow only a limited
number of measurements. TCD recordings, on the
other hand, may be obtained continuously. Although
correlation between absolute flow velocity and CBF
in any given population is poor, largely because of
variation in MCA diameter, good correlation be-
tween relative changes in flow velocity and CBF has
been demonstrated [15, 16]. Moreover, TCD studies
on carbon dioxide reactivity indicated that this may
be a particularly suitable tool for such investigations,
as multiple paired measurements are taken and linear
regression lines can be constructed more accurately
than with a limited number of conventional blood
flow measurements [15, 17, 18]. The validity of TCD
rests on the assumption that the MCA is a con-
ductance vessel and its diameter does not change
significantly with changes in Pa c o . Changes in
cerebral vascular resistance occur primarily by
dilatation of arterioles and not the arteries of the
circle of Willis [19]. Consequently, the MCA as a
conductance vessel is unlikely to be affected by
vasoactive agents. These assumptions have been
confirmed recently by Giller and colleagues who
observed during operation that the diameter of the
proximal MCA does not dilate more than 4 % during
variations in PaCO2 or arterial pressure, nor does it
change appreciably with systemic administration of
nitroprusside or phenylephrine [20]. The lack of
change in diameter with change in Pacc,2 has also
been reported previously by Huber and Handa [21].
If we accept the assumption that the MCA region
that TCD insonates does not change in diameter,
then the change in blood flow velocity is proportional
to changes in CBF. Indeed, Kirkham and co-workers
have shown that carbon dioxide reactivity deter-
mined with TCD correlates well with carbon dioxide
reactivity determined using direct methods of
measuring CBF [18].
Normal wmca varies from 35 to 90 cm s~' with a
mean of approximately 60 cm s~' during the awake
and resting states [22]. This range of umca probably
reflects individual differences in MCA diameter,
baseline CBF and the angle of insonation. The low
absolute carbon dioxide reactivity seen during
propofol-induced EEG silence can be explained by
the cerebral vasoconstrictive effect of propofol and is
consistent with results we reported previously during
propofol anaesthesia [10]. Therefore, as baseline
ornca is low, the change per kPa change in PaCOa in
absolute numbers is similarly reduced. When this is
normalized to a wmca at a PaC02 of 5.3 kPa, the
relative slope expressed as a percentage approximates
the awake value. Compared with the absolute change,
the percentage change in amca with change in Paco
shows less dependence on baseline values, is there-
fore more appropriate for statistical analysis [23],
and consequently is a more valid indicator of carbon
dioxide reactivity.
Normalizing all iraca values by expressing them
as a percentage of wmca at a Pacc,2 of 5.3 kPa also
allows comparisons with previously published
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studies. As we measured wmca and not CBF, we
could only estimate cerebral vascular resistance
(CVRe). This assumes that the changes in CBF
correlate with changes in vmca. This is not an
unreasonable assumption as changes in CBF have
been shown to correlate well with changes in wmca
[15, 16]. The index of autoregulation is then cal-
culated by dividing the percentage change in CVRe
by the percentage change in MAP. If the percentage
change in CVRe is the same as the percentage
change in MAP, no change in CBF results. Thus an
autoregulation index of 1 indicates perfect auto-
regulation, and an IOR of 0 signifies complete
absence of autoregulation. Mean IOR was 0.93
(SEM 0.02), indicating that good autoregulation was
present during propofol-induced EEG silence. We
considered a 15% deviation from IOR of 1 to be
unimportant clinically and within normal limits, as
dynamic autoregulation in normal volunteers has
been shown to have a SD of 15 % [11]. Power analysis
ensured that 10 patients were sufficient to reject the
null hypothesis with a power of 0.80. Based on this,
we found the autoregulatory capacity to be intact
during propofol-induced EEG suppression. Al-
though we only examined autoregulation in one
direction (increase in MAP), we chose a level of
MAP in the middle of the autoregulatory curve.
Therefore, there is no reason to assume that a
decrease instead of an increase in MAP would have
yielded different results.
A hallmark of normal cerebral vasculature is an
intact autoregulatory response to changes in cerebral
perfusion pressure (CPP). In the normotensive
human, autoregulation is operative over a range of
mean CPP of 50-150 mm Hg. Within this range,
cerebrovascular resistance varies directly with MAP
to maintain CBF constant. In the event of an
abrupt change in CPP, blood flow initially changes
correspondingly for a brief period (1-5 s) before the
autoregulatory mechanism returns flow to control
levels [11]. Some pathological states and pharma-
cological interventions can modify or abolish auto-
regulation. Moreover, there is evidence to suggest
autoregulation is more susceptible to perturbation
than carbon dioxide reactivity. Okuda and colleagues
have demonstrated that in baboons made hypo-
tensive by haemorrhage to an MAP beyond the lower
limit of autoregulation (MAP of 40 mm Hg), and
subsequently rendered normotensive, there was
rebound cerebral hyperaemia (i.e. lost auto-
regulation) which responded to hypocapnia (i.e.
intact carbon dioxide reactivity) [24]. In contrast,
mild to moderate head injury often impairs auto-
regulation without affecting carbon dioxide reac-
tivity [25]. In this study we investigated carbon
dioxide reactivity and autoregulation while mini-
mizing the effect of metabolic activity by rendering
the EEG isoelectric. Cerebal blood flow and
metabolism coupling is assumed generally to be
intact during i.v. anaesthesia. It has been shown that
i.v. agents such as the barbiturates produce cerebral
vasoconstriction indirectly by reducing cerebral
metabolism. Maximum reduction in CMRo2 co-
incides with the development of electrical silence in
the EEG, and additional administration of bar-
biturates results in no further reduction in CMRo2
or CBF [26]. Thus a flat EEG is considered the point
at which metabolic activity and CBF are depressed
maximally and has been used as the end-point for
cerebral protection. Although recent studies suggest
that metabolic suppression may play only a small
role in the overall scheme of cerebral protection [27],
it continues to be used clinically as a method of
cerebral protection and for reducing ICP [8, 28]. It
seems logical that in situations of reduced oxygen
delivery, keeping CMRo2 to a minimum would
increase the margin of safety in those patients at risk
of cerebral ischaemia. The use of barbiturates for
cerebral protection is associated with profound
cardiovascular depression and prolonged awakening
which may be undesirable in neurosurgical patients.
Propofol, with similar cerebral vascular effects as
thiopentone, has a relatively short duration of action
and is useful for producing short periods of cerebral
metabolic suppression without delayed awakening.
Indeed, the protective effect of propofol has been
demonstrated in an experimental ischaemic model
[12]. The effect of suppressing cortical activity to the
point of EEG silence with barbiturates has been
shown not to significantly affect carbon dioxide
reactivity in humans [29] or autoregulation in sheep
[30]. We have now confirmed that high-dose
propofol, sufficient to produce EEG silence, also
preserved carbon dioxide reactivity and auto-
regulation. The preservation of these normal homeo-
static mechanisms increases the safety of intra-
operative manipulation of arterial pressure and
carbon dioxide, at least in neurologically normal
patients. Because of its pharmacokinetic profile,
propofol may be preferable to thiopentone when
EEG suppression is indicated clinically.
We conclude that in patients without neurological
pathology, cerebral pressure autoregulation and
carbon dioxide reactivity are intact during propofol-
induced EEG silence. Whether this is true for
neurosurgical patients with intracranial pathology
requires investigation.
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